120
Participants
Start Date
December 20, 2024
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2029
Spironolactone
The doses used in the study are the doses used in standard clinical practice. Initial dose is 25 mg/day until study end . The duration of treatment for each patient is 12 months.
Placebo
Placebo will be taken once a day at the same time of day. The duration of treatment for each patient is 12 months.
NOT_YET_RECRUITING
CHU Amiens Picardie, Amiens
RECRUITING
Hôpital Cardiologique Louis Pradel, Bron
NOT_YET_RECRUITING
Hôpital Gabriel Montpied, Clermont-Ferrand
NOT_YET_RECRUITING
CHU Dijon, Dijon
NOT_YET_RECRUITING
Hôpital Michallon, Grenoble
NOT_YET_RECRUITING
Hôpital de la Timone, Marseille
NOT_YET_RECRUITING
Hôpital Arnaud de Villeneuve, Montpellier
NOT_YET_RECRUITING
Hôpital Laennec, Nantes
NOT_YET_RECRUITING
Groupe Hospitalo Universitaire Caremeau, Nîmes
NOT_YET_RECRUITING
Hôpital Pitié Salpetrière, Paris
NOT_YET_RECRUITING
Hôpital de Haut-Lévêque, Pessac
NOT_YET_RECRUITING
Nouvel Hôpital Civil, Strasbourg
NOT_YET_RECRUITING
Hôpital Rangueil, Toulouse
Hospices Civils de Lyon
OTHER